Dabrafenib medical insurance price in 2024

Dabrafenib is a targeted therapy drug used to treat certain types of cancer. It belongs to the class of BRAF (B type lymphoma kinase) inhibitors. BRAF is a protein kinase involved in cell proliferation and growth. Mutations occur in certain types of cancer, promoting the abnormal growth and spread of cancer cells.

Dabrafenib has been officially launched in China and has been included in the medical insurance system, which means that patients can directly purchase the drug in China. However, its price is about more than 10,000 yuan, which is still relatively expensive for many patients. Specific drug prices may vary by region and hospital, so patients are advised to check with their local hospital or pharmacy for accurate information.

In comparison, the price of foreign generic drugs of dabrafenib is more affordable. In particular, the price of generic drugs produced in Laos is only about two to three thousand yuan, which is far lower than the price of domestic original drugs. Despite this, the ingredients of these foreign generic drugs are basically the same as those of domestic original drugs, so patients can choose a suitable purchasing channel based on their own financial situation and doctor's advice. But please note that when purchasing medicines, you must ensure the reliability of the source and the quality and safety of the medicines.

The main application area of dabrafenib is the treatment of BRAF V600 mutant malignant melanoma, which is a more malignant form of skin cancer. In addition, it can also be used to treat BRAF V600E mutated avesicular thyroid cancer. Both cancer types are associated with specific mutations in the BRAF gene, and dabrafenib interferes with the growth and spread of cancer cells by inhibiting the activity of these mutations.

Often, dabrafenib is used in combination with other drugs to achieve better therapeutic effects. For example, it is often used in combination with Trametinib, a MEK (mitogen-activated kinase) inhibitor that further inhibits the proliferation and metastasis of cancer cells.